Secor Capital Advisors’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-21,954
| Closed | -$1.54M | – | 321 |
|
|
2019
Q1 | $1.54M | Sell |
21,954
-5,097
| -19% | -$357K | 0.32% | 90 |
|
|
2018
Q4 | $1.74M | Buy |
27,051
+4,694
| +21% | +$302K | 0.23% | 113 |
|
|
2018
Q3 | $1.57M | Sell |
22,357
-12,845
| -36% | -$902K | 0.17% | 155 |
|
|
2018
Q2 | $1.77M | Buy |
+35,202
| New | +$1.77M | 0.15% | 173 |
|
|
2017
Q3 | – | Sell |
-46,551
| Closed | -$1.52M | – | 521 |
|
|
2017
Q2 | $1.52M | Sell |
46,551
-1,703
| -4% | -$55.4K | 0.14% | 181 |
|
|
2017
Q1 | $1.52M | Sell |
48,254
-8,349
| -15% | -$263K | 0.17% | 157 |
|
|
2016
Q4 | $1.66M | Sell |
56,603
-9,933
| -15% | -$292K | 0.2% | 120 |
|
|
2016
Q3 | $1.92M | Buy |
66,536
+8,643
| +15% | +$250K | 0.21% | 128 |
|
|
2016
Q2 | $1.5M | Buy |
57,893
+11,790
| +26% | +$305K | 0.19% | 135 |
|
|
2016
Q1 | $1.14M | Buy |
46,103
+20,665
| +81% | +$512K | 0.16% | 95 |
|
|
2015
Q4 | $895K | Buy |
25,438
+14,709
| +137% | +$518K | 0.25% | 112 |
|
|
2015
Q3 | $227K | Sell |
10,729
-14,920
| -58% | -$316K | 0.07% | 376 |
|
|
2015
Q2 | $713K | Buy |
25,649
+8,138
| +46% | +$226K | 0.26% | 136 |
|
|
2015
Q1 | $535K | Buy |
17,511
+4,111
| +31% | +$126K | 0.21% | 170 |
|
|
2014
Q4 | $428K | Buy |
+13,400
| New | +$428K | 0.18% | 214 |
|
|
2014
Q3 | – | Sell |
-17,542
| Closed | -$481K | – | 406 |
|
|
2014
Q2 | $481K | Buy |
+17,542
| New | +$481K | 0.25% | 139 |
|
|
2014
Q1 | – | Sell |
-16,984
| Closed | -$497K | – | 423 |
|
|
2013
Q4 | $497K | Buy |
+16,984
| New | +$497K | 0.2% | 203 |
|